Heterocyclic compound, pharmaceutical composition, inhibitor of activation of ap-1 or an inhibitor of activation of nf-kappab, inhibitor of the production of inflammatory cytokine, and inhibitor of the production of matrix metalloprotease or inhibitor of the expression of inflammatory cell adhesion factor

摘要

"HETEROCYCLIC COMPOUND, PHARMACEUTICAL COMPOSITION, AP-1 ACTIVATION INHIBITOR OR AN NF-KAPPAB ACTIVATION INHIBITOR, INFLAMMATORY CYTOKIN PRODUCTION INHIBITOR, AND METHALOPHYDRATING DETERMINATION INHIBITOR INHIBITION OF METALOPHROTEASE DETERMINATION. INFLAMMATORY ". The present invention provides an inhibitor of AP-1 activation, an inhibitor of NF-kappaB activation, an inhibitor of inflammatory cytokine production, an inhibitor of matrix metalloprotease production or an inhibitor of inflammatory cell adhesion factor expression , which contains a heterocyclic compound or a pharmaceutically acceptable salt thereof as an active ingredient.